Life Sciences Blog
Feature
Millennial professionals say that achieving work-life integration is more important than all other job-related goals, including building wealth, according to a survey conducted by World Services Group. >
Services
Region
Industries
- Agriculture
- Corporate & Business
- Crossborder Trade & Investment
- Dispute Resolution
- Employment & Labor
- Energy & Natural Resources
- Environmental
- Financial Services
- Government & Public Sector
- Healthcare & Pharmaceuticals
- Hospitality, Media & Leisure
- Industrial & Manufacturing
- Insurance
- Life Sciences
- Real Estate & Construction
- Retail & Distribution
- Taxation
- Technology
- Telecommunications
- Transportation
Recent Posts
- Blog: Ireland IP & Technology Law BlogCJEU rules the reposting of a photograph on the internet freely accessible on another website requires reauthorisation of the authorPosted on August 16, 2018 by Davinia BrennanThe CJEU has ruled that an unauthorised reposting of a photograph on a website, which is already publicly accessible without restriction on another website, can infringe the copyright rights of a photographer (Renckhoff, C-161/17). It is of little importance if, as in the present case, the copyright holder does not limit the ways in which the photograph may be used by...Continue Reading…
- Blog: Waller Law BlogWhy QAPI could be a life-or-death decision for skilled nursing facilitiesPosted on August 15, 2018 by Jeffery D. Parrish
- Blog: Biologics BlogFDA Approves First-Ever siRNA TherapyPosted on August 9, 2018 by Today FDA approved the first-ever “small interfering RNA” (siRNA) product, marking a significant milestone in the story of RNA interference (RNAi) technology and clearing the way for a new type of therapeutic. Alnylam® secured approval and Orphan Drug Designation for its siRNA product Onpattro (patisiran), a therapy for the rare hereditary disease transthyretin-mediated amyloidosis in adult [...]
- Blog: EndpointsFormer FDA Counsel Joins Verrill Dana’s Health Care GroupPosted on July 16, 2018 by Academic and Clinical Research GroupWe are pleased to welcome attorney Katlin McKelvie Backfield to our nationally recognized Health Care Group. Katlin comes to Verrill Dana with more than 15 years of pharmaceutical regulatory experience, including more than a decade at the Food and Drug Administration. While at the FDA, Katlin served as Associate Chief Counsel for Drugs in the Office of Chief Counsel and as a Regulatory Counsel in the Division of Drug Marketing, Advertising, and Communications (DDMAC) (now the Office of Prescription Drug Promotion). Prior to joining [...]
